{
    "2018-01-11": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Elanco Announces Addition of New North America and Global Strategy Senior Executive",
                "features": {
                    "keywords": [
                        "Elanco",
                        "North America",
                        "Global Strategy",
                        "Senior Executive"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Big Pharma CEOs Speak About Impact of Tax Reform on M&A",
                "features": {
                    "keywords": [
                        "Big Pharma",
                        "CEOs",
                        "Tax Reform",
                        "M&A"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "How Mylan’s Rest of the World Segment Performed in 3Q17",
                "features": {
                    "keywords": [
                        "Mylan",
                        "Rest of the World",
                        "Segment Performance",
                        "3Q17"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Elanco, Aratana Announce Marketing Authorization of GALLIPRANT® (grapiprant tablets) in Europe",
                "features": {
                    "keywords": [
                        "Elanco",
                        "Aratana",
                        "GALLIPRANT",
                        "Marketing Authorization",
                        "Europe"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}